Mei-Wen Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mei-Wen Yu has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Hongsheng Wang
Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College
7 shared publications Le Wang
National Center for Leprosy Control, Chinese Center for Disease Control and Prevention, Hospital for Skin Diseases (Institute of Dermatology), Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, Jiangsu 210042, China
5 shared publications- Hao Wang
Sichuan Provincial People's Hospital , Chengdu , China
3 shared publications - Heng Gu
Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
3 shared publications Pei-Wen Sun
National Center for Leprosy Control, Chinese Center for Disease Control and Prevention, Hospital for Skin Diseases (Institute of Dermatology), Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, Jiangsu 210042, China
3 shared publicationsPeiwen Sun
Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China
3 shared publications
Latest Publications
- Open Access
- 27 February 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-7
Potentially disabling factors of newly diagnosed leprosy patients in southwest China: a retrospective observational study
With the prevalence of leprosy dramatically declining, the focus of leprosy control has gradually shifted from the implementation of multidrug therapy (MDT) to accelerating the reduction of the disease burden and preventing disability. Southwestern China currently bears the highest leprosy burden in China and more than half of the disability cases reported every year are from this region. However, the potential risk factors of leprosy disability in this area remain unknown. In this study, we evaluated the physical disabilities of 4578 leprosy patients in southwest China from 2010 to 2020. Clinical and epidemiological factors associated with physical disability resulting from leprosy were identified using multinomial logistic regression. A total of 4578 leprosy cases with complete information were reported in southwestern China during the 11 years. Among them, 1126 (24.60%) patients were diagnosed with grade 2 disability (G2D), and 737 (16.10%) were confirmed with grade 1 disability (G1D) at diagnosis. The potential factors associated with G2D are as follows: nerve damage, male, leprosy reaction, older age of the patient, the longer delay in diagnosis, and more skin lesions. Furthermore, nerve damage, leprosy reaction, male, older age, and longer delayed diagnosis were the main risk factors of G1D. Among them, nerve damage, older age, longer delayed diagnosis, male, and leprosy reaction were the common risk factors for G1D and G2D. In our study, we found older age, longer delayed diagnosis, male, more skin lesions, more nerve lesions, and leprosy reactions were associated with leprosy disability. These findings provide a foundation for the development of targeted interventions aimed at the early identification of individuals at higher risk of physical disability, as well as for self-care and health education to promote timely medical consultation to prevent leprosy-related disabilities.
- 27 February 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-7
Open AccessPotentially disabling factors of newly diagnosed leprosy patients in southwest China: a retrospective observational study
With the prevalence of leprosy dramatically declining, the focus of leprosy control has gradually shifted from the implementation of multidrug therapy (MDT) to accelerating the reduction of the disease burden and preventing disability. Southwestern China currently bears the highest leprosy burden in China and more than half of the disability cases reported every year are from this region. However, the potential risk factors of leprosy disability in this area remain unknown. In this study, we evaluated the physical disabilities of 4578 leprosy patients in southwest China from 2010 to 2020. Clinical and epidemiological factors associated with physical disability resulting from leprosy were identified using multinomial logistic regression. A total of 4578 leprosy cases with complete information were reported in southwestern China during the 11 years. Among them, 1126 (24.60%) patients were diagnosed with grade 2 disability (G2D), and 737 (16.10%) were confirmed with grade 1 disability (G1D) at diagnosis. The potential factors associated with G2D are as follows: nerve damage, male, leprosy reaction, older age of the patient, the longer delay in diagnosis, and more skin lesions. Furthermore, nerve damage, leprosy reaction, male, older age, and longer delayed diagnosis were the main risk factors of G1D. Among them, nerve damage, older age, longer delayed diagnosis, male, and leprosy reaction were the common risk factors for G1D and G2D. In our study, we found older age, longer delayed diagnosis, male, more skin lesions, more nerve lesions, and leprosy reactions were associated with leprosy disability. These findings provide a foundation for the development of targeted interventions aimed at the early identification of individuals at higher risk of physical disability, as well as for self-care and health education to promote timely medical consultation to prevent leprosy-related disabilities.
- Open Access
- 14 February 2024
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 1-14
Spatiotemporal pattern of leprosy in southwest China from 2010 to 2020: an ecological study
Background: Despite many efforts to control leprosy worldwide, it is still a significant public health problem in low- and middle-income regions. It has been endemic in China for thousands of years, and southwest China has the highest leprosy burden in the country. Methods: This observational study was conducted with all newly detected leprosy cases in southwest China from 2010 to 2020. Data were extracted from the Leprosy Management Information System (LEPMIS) database in China. The Joinpoint model was used to determine the time trends in the study area. Spatial autocorrelation statistics was performed to understand spatial distribution of leprosy cases. Spatial scan statistics was applied to identify significant clusters with high rate. Results: A total of 4801 newly detected leprosy cases were reported in southwest China over 11 years. The temporal trends declined stably. The new case detection rate (NCDR) dropped from 4.38/1,000,000 population in 2010 to 1.25/1,000,000 population in 2020, with an average decrease of 12.24% (95% CI: −14.0 to − 10.5; P < 0.001). Results of global spatial autocorrelation showed that leprosy cases presented clustering distribution in the study area. Most likely clusters were identified during the study period and were frequently located at Yunnan or the border areas between Yunnan and Guizhou Provinces. Secondary clusters were always located in the western counties, the border areas between Yunnan and Sichuan Provinces. Conclusions: Geographic regions characterized by clusters with high rates were considered as leprosy high-risk areas. The findings of this study could be used to design leprosy control measures and provide indications to strengthen the surveillance of high-risk areas. These areas should be prioritized in the allocation of resources.
- 14 February 2024
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 1-14
Open AccessSpatiotemporal pattern of leprosy in southwest China from 2010 to 2020: an ecological study
Background: Despite many efforts to control leprosy worldwide, it is still a significant public health problem in low- and middle-income regions. It has been endemic in China for thousands of years, and southwest China has the highest leprosy burden in the country. Methods: This observational study was conducted with all newly detected leprosy cases in southwest China from 2010 to 2020. Data were extracted from the Leprosy Management Information System (LEPMIS) database in China. The Joinpoint model was used to determine the time trends in the study area. Spatial autocorrelation statistics was performed to understand spatial distribution of leprosy cases. Spatial scan statistics was applied to identify significant clusters with high rate. Results: A total of 4801 newly detected leprosy cases were reported in southwest China over 11 years. The temporal trends declined stably. The new case detection rate (NCDR) dropped from 4.38/1,000,000 population in 2010 to 1.25/1,000,000 population in 2020, with an average decrease of 12.24% (95% CI: −14.0 to − 10.5; P < 0.001). Results of global spatial autocorrelation showed that leprosy cases presented clustering distribution in the study area. Most likely clusters were identified during the study period and were frequently located at Yunnan or the border areas between Yunnan and Guizhou Provinces. Secondary clusters were always located in the western counties, the border areas between Yunnan and Sichuan Provinces. Conclusions: Geographic regions characterized by clusters with high rates were considered as leprosy high-risk areas. The findings of this study could be used to design leprosy control measures and provide indications to strengthen the surveillance of high-risk areas. These areas should be prioritized in the allocation of resources.
- Open Access
- 31 August 2023
- Published by Wolters Kluwer Health in International Journal of Dermatology and Venereology
- Vol. 7 (1) , 35-39
Epidemiology of Leprosy in China, 2021: An Update
Objective: Leprosy is an infectious diseases that remains a concerning public health issue. The infection of Mycobacterium leprae still exists at the county level in hard-to-access areas in southwest China. An accurate analysis of the prevalence of leprosy in various regions is necessary for the formulation of prevention and control strategies, so we conducted this study to describe the epidemiological characteristics of leprosy in China in 2021 and provide essential information for future national leprosy control and prevention strategies. Methods: We collected epidemiological data of leprosy from 31 provinces, autonomous regions, and municipalities of China (except for Hong Kong, Macao, and Taiwan) provided by the Leprosy Management Information System. We performed a comparative analysis of the epidemiological features of patients with leprosy including age, sex, geographical distribution, and grade of disability. Results: In total, 374 newly detected leprosy cases were reported nationwide in China in 2021, giving an incidence rate of 0.27 per million population, which represented a decrease of 7.9% compared with 2020. Among the population with leprosy in 2021 that comprised 238 males (63.6%) and 136 females (36.4%), 1.9% (7/374) were children younger than 15 years, 92.8% (347/374) had multibacillary leprosy, and 18.2% (68/374) had grade 2 disability. More than half of the new leprosy cases (54.8%, 205/374) were distributed in southwest China. There were 33 relapsed leprosy cases reported in 2021. By the end of 2021, there were 1,897 registered leprosy cases reported nationwide, giving a prevalence rate of 1.35 per million population. Conclusion: The leprosy epidemic in China shows a downward trend in terms of the prevalence and incidence rates. However, the high prevalence of leprosy in southwest China is still a matter of concern.
- 31 August 2023
- Published by Wolters Kluwer Health in International Journal of Dermatology and Venereology
- Vol. 7 (1) , 35-39
Open AccessEpidemiology of Leprosy in China, 2021: An Update
Objective: Leprosy is an infectious diseases that remains a concerning public health issue. The infection of Mycobacterium leprae still exists at the county level in hard-to-access areas in southwest China. An accurate analysis of the prevalence of leprosy in various regions is necessary for the formulation of prevention and control strategies, so we conducted this study to describe the epidemiological characteristics of leprosy in China in 2021 and provide essential information for future national leprosy control and prevention strategies. Methods: We collected epidemiological data of leprosy from 31 provinces, autonomous regions, and municipalities of China (except for Hong Kong, Macao, and Taiwan) provided by the Leprosy Management Information System. We performed a comparative analysis of the epidemiological features of patients with leprosy including age, sex, geographical distribution, and grade of disability. Results: In total, 374 newly detected leprosy cases were reported nationwide in China in 2021, giving an incidence rate of 0.27 per million population, which represented a decrease of 7.9% compared with 2020. Among the population with leprosy in 2021 that comprised 238 males (63.6%) and 136 females (36.4%), 1.9% (7/374) were children younger than 15 years, 92.8% (347/374) had multibacillary leprosy, and 18.2% (68/374) had grade 2 disability. More than half of the new leprosy cases (54.8%, 205/374) were distributed in southwest China. There were 33 relapsed leprosy cases reported in 2021. By the end of 2021, there were 1,897 registered leprosy cases reported nationwide, giving a prevalence rate of 1.35 per million population. Conclusion: The leprosy epidemic in China shows a downward trend in terms of the prevalence and incidence rates. However, the high prevalence of leprosy in southwest China is still a matter of concern.
- Open Access
- 17 February 2023
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 17 (2) , e0011092
Leprosy among new child cases in China: Epidemiological and clinical analysis from 2011 to 2020
Background: Leprosy, caused by Mycobacterium leprae infection, mainly affects skin and peripheral nerves and may further lead to disability and deformity if not treated timely. The new case detection rate of leprosy in children reflects the active transmission of leprosy infection. This study aims to present the epidemiology and clinical characteristics of new leprosy cases in children in China from 2011 to 2020. Methodology/Principal findings: All data from leprosy patients younger than 15 years old were extracted from the Leprosy Management Information System in China (LEPMIS). Statistical Package for the Social Sciences (SPSS) version 12.0 was used for descriptive and analytical statistics of the epidemiological and clinical indicators by the Mann-Whitney test, Kruskal-Wallis test, and Fisher’s exact test. And geographical distribution was analyzed by ArcGIS 10.5. A total of 152 pediatric new cases of leprosy were found over the last decade. The new case detection rate of pediatric leprosy cases decreased from 0.13 to 0.02 per 1,000,000 population over the last ten years. New pediatric cases had a higher new case detection rate in Guizhou, Sichuan, and Yunnan Provinces. All but 7 provinces in China achieved zero new child case for consecutive five years. The onset of leprosy peaked between 10 and 14 years of age, and the male to female ratio was 1.71:1. Pediatric patients were predominantly infected from symptomatic household adult contacts HHCs. Multibacillary leprosy (MB) was the most common. However, a low proportion of patients developed leprosy reaction and grade 2 disability. Conclusions/Significance: The new case detection rate of pediatric leprosy cases has decreased over the past ten years in China. Spatial analysis indicated clusters in high-endemic areas. Leprosy transmission has stopped in the majority of provinces in China. However, sporadic cases may continue to exist for a long time. Active surveillance especially contact tracing should be focused on in future plan for management of leprosy, and interventions in leprosy clusters should be prioritized.
- 17 February 2023
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 17 (2) , e0011092
Open AccessLeprosy among new child cases in China: Epidemiological and clinical analysis from 2011 to 2020
Background: Leprosy, caused by Mycobacterium leprae infection, mainly affects skin and peripheral nerves and may further lead to disability and deformity if not treated timely. The new case detection rate of leprosy in children reflects the active transmission of leprosy infection. This study aims to present the epidemiology and clinical characteristics of new leprosy cases in children in China from 2011 to 2020. Methodology/Principal findings: All data from leprosy patients younger than 15 years old were extracted from the Leprosy Management Information System in China (LEPMIS). Statistical Package for the Social Sciences (SPSS) version 12.0 was used for descriptive and analytical statistics of the epidemiological and clinical indicators by the Mann-Whitney test, Kruskal-Wallis test, and Fisher’s exact test. And geographical distribution was analyzed by ArcGIS 10.5. A total of 152 pediatric new cases of leprosy were found over the last decade. The new case detection rate of pediatric leprosy cases decreased from 0.13 to 0.02 per 1,000,000 population over the last ten years. New pediatric cases had a higher new case detection rate in Guizhou, Sichuan, and Yunnan Provinces. All but 7 provinces in China achieved zero new child case for consecutive five years. The onset of leprosy peaked between 10 and 14 years of age, and the male to female ratio was 1.71:1. Pediatric patients were predominantly infected from symptomatic household adult contacts HHCs. Multibacillary leprosy (MB) was the most common. However, a low proportion of patients developed leprosy reaction and grade 2 disability. Conclusions/Significance: The new case detection rate of pediatric leprosy cases has decreased over the past ten years in China. Spatial analysis indicated clusters in high-endemic areas. Leprosy transmission has stopped in the majority of provinces in China. However, sporadic cases may continue to exist for a long time. Active surveillance especially contact tracing should be focused on in future plan for management of leprosy, and interventions in leprosy clusters should be prioritized.
- 1 August 2022
- Published by Wiley in International Journal of Dermatology
- Vol. 61 (12) , 1532-1539
Suspicious symptom monitoring for leprosy: an optimal practice for early detection under a low endemic situation in Zhejiang Province, China
Background: Leprosy is a chronic infectious disease that causes disabilities and deformities. Early detection is a major strategy for leprosy control. This study reported a new practice of suspicious symptom monitoring for early detection of leprosy.Methods: A descriptive and comparative analysis between a non‐strategy group of pre‐implementation of suspicious symptom monitoring in 2005–2011 and a strategy group of strategy implementation in 2012–2018 was conducted through indicators of the number of times of misdiagnoses, delayed period, proportion of early detected cases, and proportion of disabilities.Result: Compared with the non‐strategy group in 2005–2011, the median number of times of misdiagnoses was decreased from two times to zero times (z = 4.387, P < 0.001), and the median delayed period of newly detected cases were shortened from 24 months to 13 months (z = 2.381, P < 0.001), the proportion of early detected cases was increased from 43.7% to 75.2% (χ2 = 29.464, P < 0.001), the proportion of grade 2 disabilities was decreased from 28.6% in the highest year of 2005 to 4.0% in the lowest year of 2014, and the average proportion of disabilities was decreased from 33.5% to 17.6% (χ2 = 9.421, P = 0.002) in the strategy group in 2012–2018, respectively.Conclusion: Suspicious symptom monitoring promoted early detection of cases by reducing the number of times misdiagnosis of leprosy patients, shortening the delayed period, increasing the proportion of early detection, and decreasing the proportion of disabilities. It is an important and recommendable public health strategy for leprosy prevention and control in a low epidemic condition.
- 1 August 2022
- Published by Wiley in International Journal of Dermatology
- Vol. 61 (12) , 1532-1539
Suspicious symptom monitoring for leprosy: an optimal practice for early detection under a low endemic situation in Zhejiang Province, China
Background: Leprosy is a chronic infectious disease that causes disabilities and deformities. Early detection is a major strategy for leprosy control. This study reported a new practice of suspicious symptom monitoring for early detection of leprosy.Methods: A descriptive and comparative analysis between a non‐strategy group of pre‐implementation of suspicious symptom monitoring in 2005–2011 and a strategy group of strategy implementation in 2012–2018 was conducted through indicators of the number of times of misdiagnoses, delayed period, proportion of early detected cases, and proportion of disabilities.Result: Compared with the non‐strategy group in 2005–2011, the median number of times of misdiagnoses was decreased from two times to zero times (z = 4.387, P < 0.001), and the median delayed period of newly detected cases were shortened from 24 months to 13 months (z = 2.381, P < 0.001), the proportion of early detected cases was increased from 43.7% to 75.2% (χ2 = 29.464, P < 0.001), the proportion of grade 2 disabilities was decreased from 28.6% in the highest year of 2005 to 4.0% in the lowest year of 2014, and the average proportion of disabilities was decreased from 33.5% to 17.6% (χ2 = 9.421, P = 0.002) in the strategy group in 2012–2018, respectively.Conclusion: Suspicious symptom monitoring promoted early detection of cases by reducing the number of times misdiagnosis of leprosy patients, shortening the delayed period, increasing the proportion of early detection, and decreasing the proportion of disabilities. It is an important and recommendable public health strategy for leprosy prevention and control in a low epidemic condition.
- Open Access
- 21 June 2022
- Published by Wolters Kluwer Health in International Journal of Dermatology and Venereology
- Vol. 5 (4) , 231-235
Epidemiological Features of Leprosy in China, 2020
Objective: To describe the epidemiological characteristics of leprosy in China in 2020 and provide a basis for optimizing leprosy prevention and control strategies. Methods: We collected leprosy data from the Leprosy Management Information System in China, which includes data from 31 provinces, autonomous regions, and municipalities, except for Hong Kong, Macao, and Taiwan, and then performed a descriptive analysis of these data. Results: A total of 406 newly detected leprosy cases were reported nationwide in China in 2020, giving an incidence rate of 0.29 per 1,000,000 population. Among the population with leprosy, the proportions of children younger than 15 years, multibacillary cases, and cases with grade 2 disability were 1.2%, 93.3%, and 17.7%, respectively. Southwest China was the region with the largest proportion of new leprosy cases (54.7%). There were 31 relapse leprosy cases reported in 2020. By the end of 2020, there were 1,893 registered leprosy cases reported nationwide, giving a prevalence rate of 1.35 per 1,000,000 population. Conclusion: Leprosy is at a low endemic level in China in terms of the prevalence and incidence rates. However, the geographical distribution of leprosy in China is unbalanced; leprosy is highly endemic in southwest China, including Yunnan, Guizhou, Sichuan, Guangdong, and Guangxi.
- 21 June 2022
- Published by Wolters Kluwer Health in International Journal of Dermatology and Venereology
- Vol. 5 (4) , 231-235
Open AccessEpidemiological Features of Leprosy in China, 2020
Objective: To describe the epidemiological characteristics of leprosy in China in 2020 and provide a basis for optimizing leprosy prevention and control strategies. Methods: We collected leprosy data from the Leprosy Management Information System in China, which includes data from 31 provinces, autonomous regions, and municipalities, except for Hong Kong, Macao, and Taiwan, and then performed a descriptive analysis of these data. Results: A total of 406 newly detected leprosy cases were reported nationwide in China in 2020, giving an incidence rate of 0.29 per 1,000,000 population. Among the population with leprosy, the proportions of children younger than 15 years, multibacillary cases, and cases with grade 2 disability were 1.2%, 93.3%, and 17.7%, respectively. Southwest China was the region with the largest proportion of new leprosy cases (54.7%). There were 31 relapse leprosy cases reported in 2020. By the end of 2020, there were 1,893 registered leprosy cases reported nationwide, giving a prevalence rate of 1.35 per 1,000,000 population. Conclusion: Leprosy is at a low endemic level in China in terms of the prevalence and incidence rates. However, the geographical distribution of leprosy in China is unbalanced; leprosy is highly endemic in southwest China, including Yunnan, Guizhou, Sichuan, Guangdong, and Guangxi.
- Open Access
- 1 July 2021
- Published by Taylor & Francis in Pharmacogenomics and Personalized Medicine
- Vol. ume 14, 813-821
Single-Nucleotide Polymorphisms Related to Leprosy Risk and Clinical Phenotypes Among Chinese Population
Background: Genome-wide association studies (GWASs) have identified some immune-related single-nucleotide polymorphisms (SNPs) to be associated with leprosy. Methods: This study investigated the association of 17 SNPs based on previously published GWAS studies with susceptibility to leprosy, different polar forms and immune states of leprosy in a case–control study from southwestern China, including 1344 leprosy patients and 2732 household contacts (HHCs) (1908 relatives and 824 genetically unrelated contact individuals). The differences of allele distributions were analyzed using chi-squared analysis and logistic regression. Results: After adjusting covariate factors, rs780668 and rs3764147 polymorphisms influenced susceptibilities to genetically related or unrelated leprosy contact individuals. rs142179458 was associated with onset early cases, rs73058713 A allele and rs3764147 A allele increased the risk of reversal reaction, while rs3764147 G allele had higher risk to present lepromatous leprosy and erythema nodosum leprosum. Conclusion: Our results demonstrated that genetic variants in the LACC1, HIF1A, SLC29A3 and CDH18 genes were positively correlated with the occurrence of leprosy and leprosy clinical phenotypes, providing new insights into the immunogenetics of the disease.
- 1 July 2021
- Published by Taylor & Francis in Pharmacogenomics and Personalized Medicine
- Vol. ume 14, 813-821
Open AccessSingle-Nucleotide Polymorphisms Related to Leprosy Risk and Clinical Phenotypes Among Chinese Population
Background: Genome-wide association studies (GWASs) have identified some immune-related single-nucleotide polymorphisms (SNPs) to be associated with leprosy. Methods: This study investigated the association of 17 SNPs based on previously published GWAS studies with susceptibility to leprosy, different polar forms and immune states of leprosy in a case–control study from southwestern China, including 1344 leprosy patients and 2732 household contacts (HHCs) (1908 relatives and 824 genetically unrelated contact individuals). The differences of allele distributions were analyzed using chi-squared analysis and logistic regression. Results: After adjusting covariate factors, rs780668 and rs3764147 polymorphisms influenced susceptibilities to genetically related or unrelated leprosy contact individuals. rs142179458 was associated with onset early cases, rs73058713 A allele and rs3764147 A allele increased the risk of reversal reaction, while rs3764147 G allele had higher risk to present lepromatous leprosy and erythema nodosum leprosum. Conclusion: Our results demonstrated that genetic variants in the LACC1, HIF1A, SLC29A3 and CDH18 genes were positively correlated with the occurrence of leprosy and leprosy clinical phenotypes, providing new insights into the immunogenetics of the disease.
- Open Access
- 16 January 2020
- Published by Wolters Kluwer Health in International Journal of Dermatology and Venereology
- Vol. 3 (1) , 27-30
Epidemiological Characteristics of Leprosy in China, 2018
Objective: To describe the epidemiological characteristics of leprosy in China in 2018 and provide the essential evidences for leprosy control. Methods: We collected data of leprosy cases nationwide from Leprosy Management Information System in China (LEPMIS) except Hong Kong, Macao, and Taiwan. And then we performed a descriptive and comparative analysis. Results: A total of 521 new leprosy cases were detected nationwide in 2018, with a case detection rate of 0.037/100,000. The proportion of children under 15 years of age, multi-bacillary (MB) cases, and cases with WHO grade 2 disability (G2D) were 1.3%, 89.4%, and 19.0%, respectively. There were 2,479 registered cases of leprosy in China by the end of 2018, accounting for a prevalence rate of 0.178/100,000, with 43 replase cases. Southwest China separately accounted for 312/521 (59.9%) newly detected cases and 1180/2479 (47.6%) registered cases of leprosy in China. Conclusion: China is a low endemic country for leprosy and the detection rate was much lower than the global average. Southwest China is still the key regions for leprosy control, including Yunnan, Guizhou, and Sichuan. In addition, leprosy in low endemic provinces also needs to be focused.
- 16 January 2020
- Published by Wolters Kluwer Health in International Journal of Dermatology and Venereology
- Vol. 3 (1) , 27-30
Open AccessEpidemiological Characteristics of Leprosy in China, 2018
Objective: To describe the epidemiological characteristics of leprosy in China in 2018 and provide the essential evidences for leprosy control. Methods: We collected data of leprosy cases nationwide from Leprosy Management Information System in China (LEPMIS) except Hong Kong, Macao, and Taiwan. And then we performed a descriptive and comparative analysis. Results: A total of 521 new leprosy cases were detected nationwide in 2018, with a case detection rate of 0.037/100,000. The proportion of children under 15 years of age, multi-bacillary (MB) cases, and cases with WHO grade 2 disability (G2D) were 1.3%, 89.4%, and 19.0%, respectively. There were 2,479 registered cases of leprosy in China by the end of 2018, accounting for a prevalence rate of 0.178/100,000, with 43 replase cases. Southwest China separately accounted for 312/521 (59.9%) newly detected cases and 1180/2479 (47.6%) registered cases of leprosy in China. Conclusion: China is a low endemic country for leprosy and the detection rate was much lower than the global average. Southwest China is still the key regions for leprosy control, including Yunnan, Guizhou, and Sichuan. In addition, leprosy in low endemic provinces also needs to be focused.
- Open Access
- 1 January 2020
- Published by Chinese Center for Disease Control and Prevention in China CDC Weekly
- Vol. 2 (4) , 49-52
Towards a Leprosy-Free Country — China, 2011−2018
What is already known about this topic? Leprosy is a chronic infectious disease that is endemic in several countries. Control of leprosy has had targets set by World Health Organization’s (WHO) Global Strategy 2016–2020 and by China through a national leprosy-control plan (2011–2020). What is added by this report? Data from the Leprosy Management Information System in China was analyzed and showed a national prevalence of 0.178 per 100,000 and detection rate of 0.037 per 100,000 residents in 2018. In addition, all the main targets for 2020 have been met by 2018 except for the proportion of counties or cities to reach a prevalence of less than 1/100,000 and the proportion of children cases with grade 2 disability (G2D). What are the implications for public health practice? There are still challenges remaining to close the gaps between current progress and the targets set forth by the WHO and China. However, lessons learned in China in developing and implementing the national program may be invaluable for future plans to achieve and sustain elimination of leprosy at global and country level.
- 1 January 2020
- Published by Chinese Center for Disease Control and Prevention in China CDC Weekly
- Vol. 2 (4) , 49-52
Open AccessTowards a Leprosy-Free Country — China, 2011−2018
What is already known about this topic? Leprosy is a chronic infectious disease that is endemic in several countries. Control of leprosy has had targets set by World Health Organization’s (WHO) Global Strategy 2016–2020 and by China through a national leprosy-control plan (2011–2020). What is added by this report? Data from the Leprosy Management Information System in China was analyzed and showed a national prevalence of 0.178 per 100,000 and detection rate of 0.037 per 100,000 residents in 2018. In addition, all the main targets for 2020 have been met by 2018 except for the proportion of counties or cities to reach a prevalence of less than 1/100,000 and the proportion of children cases with grade 2 disability (G2D). What are the implications for public health practice? There are still challenges remaining to close the gaps between current progress and the targets set forth by the WHO and China. However, lessons learned in China in developing and implementing the national program may be invaluable for future plans to achieve and sustain elimination of leprosy at global and country level.
- Open Access
- 1 January 2019
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 8 (1) , 1479-1489
Molecular surveillance of antimicrobial resistance and transmission pattern of Mycobacterium leprae in Chinese leprosy patients
Reports on antimicrobial resistance (AMR) of Mycobacterium leprae, relationship with bacteriological index (BI), and transmission in China are limited. We investigated the emergence of AMR mutations, the relationship between BI and AMR in complete, moderate and lack of BI decline cases, and molecular epidemiological features of AMR cases by enrolling 290 leprosy cases from four endemic provinces. Seven (2.41%), one (0.34%), five (1.72%), one (0.34%), and one (0.34%) strains had single mutations in folP1, rpoC, gyrA, gyrB, and 23S rRNA, respectively. Double mutations in folP1 and gyrA, rpoB and gyrA, and gyrA and 23S rRNA were observed in one (0.34%) strain each. Mutated strains occurred in three out of 81 (95% CI−0.005-0.079, p = 0.083) cases with complete BI decline, in seven out of 103 (95% CI 0.018-0.117, p = 0.008) cases with moderate BI decline, and in four out of 34 (95% CI 0.003-0.231, p = 0.044) cases with lack of BI decline. Most of these mutated strains were geographically separated and diverged genotypically. AMR mutations may not be the main cause of the lack of BI decline. The low transmission of AMR strains at the county level indicates an ongoing transmission at close contact levels.
- 1 January 2019
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 8 (1) , 1479-1489
Open AccessMolecular surveillance of antimicrobial resistance and transmission pattern of Mycobacterium leprae in Chinese leprosy patients
Reports on antimicrobial resistance (AMR) of Mycobacterium leprae, relationship with bacteriological index (BI), and transmission in China are limited. We investigated the emergence of AMR mutations, the relationship between BI and AMR in complete, moderate and lack of BI decline cases, and molecular epidemiological features of AMR cases by enrolling 290 leprosy cases from four endemic provinces. Seven (2.41%), one (0.34%), five (1.72%), one (0.34%), and one (0.34%) strains had single mutations in folP1, rpoC, gyrA, gyrB, and 23S rRNA, respectively. Double mutations in folP1 and gyrA, rpoB and gyrA, and gyrA and 23S rRNA were observed in one (0.34%) strain each. Mutated strains occurred in three out of 81 (95% CI−0.005-0.079, p = 0.083) cases with complete BI decline, in seven out of 103 (95% CI 0.018-0.117, p = 0.008) cases with moderate BI decline, and in four out of 34 (95% CI 0.003-0.231, p = 0.044) cases with lack of BI decline. Most of these mutated strains were geographically separated and diverged genotypically. AMR mutations may not be the main cause of the lack of BI decline. The low transmission of AMR strains at the county level indicates an ongoing transmission at close contact levels.